Karl A Merrick Selected Research

palbociclib

1/2019

Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karl A Merrick Research Topics

Disease

7	Neoplasms (Cancer) 01/2019 - 03/2007
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Inflammation (Inflammations) 01/2018
1	Lung Neoplasms (Lung Cancer) 11/2015
1	Nijmegen Breakage Syndrome 08/2012
1	Chromosome Duplication 05/2010

Drug/Important Bio-Agent (IBA)

3	Phosphotransferases (Kinase)IBA 01/2019 - 08/2012
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 12/2015 - 11/2015
2	DNA (Deoxyribonucleic Acid)IBA 11/2015 - 05/2010
2	Adenosine Triphosphate (ATP)IBA 08/2012 - 03/2007
1	abemaciclibIBA 01/2019
1	palbociclibIBA 01/2019
1	ribociclibIBA 01/2019
1	CytokinesIBA 01/2018
1	MAP-kinase-activated kinase 2IBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 11/2015
1	RNA (Ribonucleic Acid)IBA 11/2015
1	Cyclin-Dependent Kinase 2IBA 04/2012
1	rho Guanine Nucleotide Dissociation Inhibitor gammaIBA 12/2007

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 12/2015 - 11/2015
1	Therapeutics 12/2007